ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1493	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1135	PSS is the multi-billionaire here in the IBRX story. Not only is he a brilliant	bobbseytwins2001	2	8/15/2025
1134	If PSS wanted to send a loud and clear message to the marketplace he would avoid	galt	6	8/15/2025
1133	The risk is dilution. With only limited current approvals for Anktiva, there is	Olecranon	2	8/15/2025
1132	Come on guys! These people are trying to run a small biotech company, and they	bobbseytwins2001	6	8/14/2025
1131	I do agree that the Keystone Cops crew now at the FDA is a serious problem for a	jargonweary	2	8/14/2025
1130	Absent some truly meteoric news or change in status, I remain pessimistic about	Olecranon	-	8/14/2025
1129	The lack of follow through today is as disappointing as it is unsurprising	jargonweary	1	8/14/2025
1128	From Xai x.com	End2War	-	8/14/2025
1127	New long covid trials. One already recruiting. clinicaltrials.gov clinicaltri	mannamal	-	8/14/2025
1126	D. Boral Capital Maintains Buy on ImmunityBio, Maintains $24 Price Target BENZIN	luckydog88	2	8/14/2025
1125	The Quilt-106 trial (NCT06334991, N=10) in SA does not include Anktiva. In the Q	Huggenberg	2	8/14/2025
1124	My question to Chat-GPT5 and its response: Question: Review this PR from IB	End2War	3	8/13/2025
1123	Nice volume. Gotta work on that 77M short position …	erippetoe	1	8/13/2025
1122	I could be wrong but I don’t think this trial involves anktiva fwiw. At least I	erippetoe	-	8/13/2025
1121	I had also noted this a few days ago, and while it’s yet more validation of Ankt	Fitzhughlaw	4	8/13/2025
1120	ImmunityBio Reports Complete Responses in Non-Hodgkin Waldenstrom Lymphoma Patie	erippetoe	5	8/13/2025
1119	I find it significant that we're attending Bio-Europe in November. informac	mannamal	-	8/13/2025
1118	Oops	mannamal	-	8/13/2025
1117	clinicaltrials.gov	mannamal	-	8/6/2025
1116	finance.yahoo.com includes: Cash Position: $153.7 million in cash, cash equiva	luckydog88	2	8/5/2025
1115	Cash reported was as of June 30, per press release. “The Company ended the quar	CCS648	1	7/25/2025
1114	Have not seen 8K. If 157 was report as cash in quarterly earnings it would be b	Davidoff	-	7/25/2025
1113	157M cash before offering?? any way to tell?	urslor	-	7/25/2025
1112	Good ole Boral (EF Hutton) loves some IBRX @ $30. Hopefully someday soon he wil	Davidoff	1	7/25/2025
1111	market agrees with you for now. but its been a few weeks since we got this :)	luckydog88	-	7/25/2025

Go to reply# or date (mm/dd/yy):